Literature DB >> 12805

Mechanism of the inhibitory effect of glyoxylate plus oxaloacetate and oxalomalate on the NADP-specific isocitrate dehydrogenase.

O C Ingebretsen.   

Abstract

The effects of glyoxylate plus oxaloacetate and of oxalomalate on the NADP-linked isocitrate dehydrogenase (threo-DS-isocitrate:NADP+ oxidoreductase (decarboxylating, EC 1.1.1.42) from pig heart from been studied with steady state methods as well as with stopped flow technique. When equimolar mixtures of glyoxylate and oxaloacetate were premixed for different lengths of time prior to addition to the assay mixture, the extent of inhibition increased with the premixing time. The results indicated that the inhibition by glyoxylate plus oxaloacetate is caused by a compound formed in a reversible interaction between the two components. Glyoxylate plus oxaloacetate and oxalomalate affected the enzyme in at least three different ways. They inhibited the enzyme in a reaction competitive with regard to the substrate isocitrate. This inhibition needed a certain time to be fully expressed. The time lag could be eliminated by premixing of the enzyme and inhibitor with NADP plus metal ion. Secondly, if the enzyme is premixed with NADP plus metal ions, a time lag occurs before the reaction rate approaches a constant value after initiation of the reaction with isocitrate. The inhibitors were found to enhance this effect of NADP plus metal ions on the enzyme. Thirdly, it has previously been shown that the enzyme can be activated by metal complexing agents. Glyoxylate plus oxaloacetate as well as oxalomalate are able to form complexes with metal ions and were found to cause an initial activation of the enzyme under certain assay conditions. The controversy regarding the mechanism of action of the above inhibitors on the enzyme is probably due to the fact that they affect the enzyme in several different ways.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 12805     DOI: 10.1016/0005-2744(76)90180-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Inhibition of aconitase in citrus fruit callus results in a metabolic shift towards amino acid biosynthesis.

Authors:  Asfaw Degu; Bayissa Hatew; Adriano Nunes-Nesi; Ludmila Shlizerman; Naftali Zur; Ehud Katz; Alisdair R Fernie; Eduardo Blumwald; Avi Sadka
Journal:  Planta       Date:  2011-04-28       Impact factor: 4.116

2.  The expression and significance of IDH1 and p53 in osteosarcoma.

Authors:  Xiang Hu; Ai-Xi Yu; Bai-Wen Qi; Tao Fu; Gang Wu; Min Zhou; Jun Luo; Jun-Hua Xu
Journal:  J Exp Clin Cancer Res       Date:  2010-05-07

3.  Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.

Authors:  Shimin Zhao; Yan Lin; Wei Xu; Wenqing Jiang; Zhengyu Zha; Pu Wang; Wei Yu; Zhiqiang Li; Lingling Gong; Yingjie Peng; Jianping Ding; Qunying Lei; Kun-Liang Guan; Yue Xiong
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

4.  Antioxidant enzyme inhibitors enhance peroxynitrite-induced cell death in U937 cells.

Authors:  Eun Sun Yang; Jeen-Woo Park
Journal:  Mol Cell Biochem       Date:  2007-01-06       Impact factor: 3.842

5.  Oxalomalate reduces expression and secretion of vascular endothelial growth factor in the retinal pigment epithelium and inhibits angiogenesis: Implications for age-related macular degeneration.

Authors:  Sung Hwan Kim; Hyunjin Kim; Hyeong Jun Ku; Jung Hyun Park; Hanvit Cha; Seoyoon Lee; Jin Hyup Lee; Jeen-Woo Park
Journal:  Redox Biol       Date:  2016-10-24       Impact factor: 11.799

6.  Decreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer.

Authors:  Jieying Li; Jianfei Huang; Fang Huang; Qing Jin; Huijun Zhu; Xudong Wang; Meng Chen
Journal:  Oncotarget       Date:  2016-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.